gold has been researched along with mdv 3100 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Rejaie, SS; Baker, A; Elgorban, AM; Mohany, M; Sajid Khan, M; Syed, A | 1 |
1 other study(ies) available for gold and mdv 3100
| Article | Year |
|---|---|
Survivin-targeted nanomedicine for increased potency of abiraterone and enzalutamide against prostate cancer.
Topics: Gold; Humans; Male; Metal Nanoparticles; Nanomedicine; Prostatic Neoplasms, Castration-Resistant; Survivin | 2023 |